Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:ATCCode |
L04AA56
|
| gptkbp:CASNumber |
1334298-90-6
|
| gptkbp:developedBy |
gptkb:Incyte_Corporation
|
| gptkbp:hasMolecularFormula |
C22H22N6O
|
| gptkbp:hasSMILES |
CCc1cnn(n1)C[C@@H](n2cnc3c(N)ncnc32)c4cn(nc4)C
|
| gptkbp:hasUNII |
6Q1K1Y1A2E
|
| https://www.w3.org/2000/01/rdf-schema#label |
itacitinib
|
| gptkbp:IUPACName |
2-[(1S)-1-(4-ethyl-1H-pyrazol-1-yl)ethyl]-9-(1-methyl-1H-pyrazol-4-yl)-9H-purin-6-amine
|
| gptkbp:mechanismOfAction |
JAK1 inhibitor
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL3544943
57379313 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
INCB 039110
INCB039110 |
| gptkbp:usedInClinicalTrialsFor |
gptkb:graft-versus-host_disease
solid tumors hematologic malignancies |
| gptkbp:bfsParent |
gptkb:Janus_kinases
|
| gptkbp:bfsLayer |
8
|